Ann: Paradigm receives clarity on US regulatory pathway, page-41

The fact that institutional investors grabbed the shares at $1.30 within hours tell us something. They where fighting to get them at that price.
So the chances are that the share price will end up there or go lower for the short term. The only thing that has changed here is that the
time lines have drifted out a little.If your long , than it doesn’t really matter, in 12 months time these prices will look incredible cheap in my opinion. Once PAR get TGA approval there will be nothing holding back the share price, and of we go in the big money game, in the mean time, big pharmaceutical will be circling I’m sure.
I see this personally as an opportunity to top up , and top up big as it could be the last time we see these prices again.
GLTA